[1]
K. Umini, “a literatur review IMPACT SGLT2 INHIBITORS ( Dapagliflozin and Empagliflozin) IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HFrEF): a scoping review”, medfarm, vol. 13, no. 2, pp. 257-278, Jan. 2025.